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Abstract : Background : Diaphragm dysfunction is a serious problem. However, a few management techniques 
exist for diaphragm dysfunction. Methods : Adult patients treated with high-flow nasal cannula (HFNC) in the 
intensive care unit were included in this study. The diaphragm function was evaluated using ultrasound mea-
surement of thickening fraction before and after HFNC liberation. Normal diaphragm contraction was defined 
as thickening fraction ≥ 15% without HFNC, whereas decreased or paradoxical diaphragm contractions were 
0%–15% or < 0%, respectively. Results : Forty patients were enrolled, and 16 (40%) had normal diaphragm contrac-
tion, whereas 19 (48%) or 5 (13%) had decreased or paradoxical diaphragm contractions, respectively. Thicken-
ing fraction increased after HFNC liberation (27.0% ± 25.7% vs. 38.8% ± 34.5%,  p = 0.03 in HFNC vs. no HFNC) in 
patients without diaphragm dysfunction. In patients with decreased diaphragm contraction, thickening fraction 
did not change with or without HFNC (8.9% ± 11.7% vs. 6.7% ± 5.2%,  p = 0.35), whereas paradoxical contraction de-
creased with HFNC (1.0% ± 10.2% vs. –10.3% ± 2.7%,  p = 0.04) in patients with paradoxical diaphragm contraction. 
Conclusions : The work of breathing decreased with HFNC in patients without diaphragm dysfunction, but did 
not decrease in patients with decreased diaphragm contraction. Paradoxical diaphragm contraction decreased 
with HFNC. J. Med. Invest. 68 : 159-164, February, 2021
Keywords : Diaphragm, Ultrasonography, Intensive Care Unit, Respiration, Atrophy
BACKGROUND
 
Patients undergoing prolonged mechanical ventilation expe-
rience diaphragm atrophy and dysfunction (1, 2). Diaphragm 
atrophy occurs in 63% of mechanically ventilated patients (3). 
Moreover, diaphragm atrophy is associated with diaphragm 
dysfunction, termed as ventilator-induced diaphragm dysfunction. 
Diaphragm dysfunction is defined as a loss of diaphragmatic 
force-generating capacity that includes paradoxical diaphrag-
matic contraction. Diaphragm dysfunction has been reported to 
worsen clinical outcomes (4).
Several strategies, such as ventilator settings, exist to pre-
vent diaphragm atrophy and dysfunctions (5, 6). The strategy 
of ventilator setting is termed as diaphragm protective ventilation, 
which requires the preservation of spontaneous breathing and 
the reduction of excessive pressure support (7). However, only 
a few recommendations have been made for the management 
and treatment of diaphragm dysfunction. Although mechanical 
ventilation may be required for severe diaphragm dysfunction, 
high-flow nasal cannula (HFNC) may attenuate diaphragm 
dysfunction because it washes out carbon dioxide in anatomical 
dead space, increases lung volume, and decreases the work of 
breathing (8).
We hypothesized that HFNC could contribute to diaphragm 
dysfunction. Because HFNC decreases the work of breathing, 
it may support diaphragm dysfunction including paradoxi-
cal diaphragm contraction. However, no previous study has 
investigated the effect of HFNC therapy on diaphragm dysfunc-
tion. Therefore, this observational study was conducted to evalu-
ate the effect of HFNC on diaphragm function using ultrasound, 
which is a validated method to assess diaphragm function (9). 
METHODS
Study design
This observational study was conducted in the intensive 
care units (ICU) of Tokushima University Hospital between 
June 2018 and June 2020. This study was approved by clinical 
research ethics committees at Tokushima University Hospi-
tal (approval number 3299) and registered on a clinical trial 
(UMIN-Clinical Trials Registry : 000038082). Written in-
formed consent was obtained at the time of enrollment from 
patients or their authorized surrogate decision-makers. 
Study population
Adult patients who were treated with HFNC in the ICU were 
included in this study. The OptiflowTM system with an O2 / air 
blender and a heated humidifier at 40°C (MR850, Fisher & 
Paykel Healthcare, Auckland, New Zealand) was used. On the 
one hand, patients were liberated from HFNC when the HFNC 
setting was weaned to 30 L  / min flow at FIO2 of 0.21–0.30. On 
the other hand, patients were eligible when oxygen saturation 
was ≥ 90% with respiratory rate < 40 / min. Exclusion criteria 
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were < 18 years, trauma or chest tube at the measurement point, 
diagnosis of primary neuromuscular disease, suspicion of phren-
ic nerve palsy, pneumothorax, massive pleural effusion, and an 
unclear ultrasound image. If the patients met the criteria of oxy-
gen saturation < 90% with supplemental oxygen, respiratory rate 
> 40 / min, and increased work of breathing with dyspnea after 
liberation from HFNC, they were withdrawn from the study 
with the use of HFNC again.
Measurements of diaphragm function 
Diaphragm function was evaluated with ultrasound 30 min 
before and after HFNC liberation. HI VISION Preirus with a 
6.5-MHz linear or 1–5-MHz convex transducer (EUP-L73S or 
EUP-C715, Hitachi Medical Corporation, Tokyo, Japan) was 
used for ultrasonography. All scanning was done in bed at an 
angle of 30°. Diaphragm dysfunction was decided by thickening 
fraction. Moreover, in thickening fraction, a linear transducer 
was placed perpendicular to the right chest wall at the zone of 
apposition with B mode, 0.5–2 cm below the costophrenic sinus, 
between the eighth and tenth intercostal spaces, and between 
the anteroaxillary and the midaxillary line (Figure 1A). The 
diaphragm in this area is observed as a three-layered structure 
consisting of the hypoechogenic muscular layer bounded by echo-
genic membranes of the peritoneum and diaphragmatic pleura 
(Figure 1B). Measurements were conducted at inspiration and 
end-expiration. Thickening fraction was calculated as [thickness 
at inspiration−thickness at expiration]   /   [thickness at expiration] 
× 100 (%). The normal range of thickening fraction is ≥ 15% 
during spontaneous breathing in healthy adults (4). On one hand, 
decreased diaphragm contraction was defined as 0%–15% with-
out HFNC, and paradoxical diaphragm contraction was defined 
as < 0%. In addition to thickening fraction, diaphragm excursion 
was evaluated in the subcostal area with a convex transducer 
using M mode (Figure 1C). Diaphragm excursion is the distance 
from the lower to the upper curve of diaphragm movement (Fig-
ure 1D). The normal range of diaphragm excursion is > 1 cm. 
Diaphragm contraction velocity is diaphragm excursion divided 
by the inspiratory time, and excursion–time index is the product 
of diaphragm excursion and inspiratory time. Measurements 
were conducted three times, and the median value was used for 
evaluation. All measurements were performed by two ICU physi-
cians (T.T. and N.N.). Intra- and interobserver correlations were 
0.89 and 0.89 at thickening fraction and 0.90 and 0.91 at excur-
sion, respectively. Intra- and interobserver Bland-Altman plots 
were 0.58 (± 1.50 ; 95% confidence interval [CI] −2.41–3.56) and 
−1.68 (± 1.24 ; 95% CI −4.15–0.79) at thickening fraction and 
−0.01 (± 0.04 ; 95% CI −0.08–0.06) and 0.05 (± 0.03 ; 95% CI 
−0.02–0.11) at excursion.
Statistical analysis
A feasible sample size of 40 patients was planned. Continuous 
data were presented as means ± standard deviation or medians 
(interquartile range [IQR]), whereas categorical data were ex-
pressed as numbers (in percentage). Variables obtained before 
and after HFNC liberation were compared by paired t-test. 
Multiple comparisons were conducted using one-way analysis 
of variance (ANOVA) or Kruskal–Wallis test with post hoc 
comparisons using Tukey-Kramer or Steel–Dwass test. Data 
analyses were conducted using JMP 13.1.0 (SAS Institute, Cary, 
NC, USA). All statistical tests were two-tailed, and a p value < 
0.05 was regarded as statistically significant.
RESULTS
The characteristics of the patients are shown in Table 1. Forty 
patients (23 males, 17 females ; age 69 ± 16 years) were enrolled. 
Acute Physiology and Chronic Health Evaluation II score was 18 
Figure 1.　Ultrasound measurements of the diaphragm. A Measurement site of thickening fraction, B Ultrasound image of 
diaphragm thickness, C Measurement site of diaphragm excursion, and D Ultrasound image of excursion and inspiratory time.
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(IQR, 12–26). The HFNC duration was 2 days (IQR, 2–3 days), 
which was due to post-extubation (29 patients, 73%) and respira-
tory failure types I (10 patients, 25%) and II (1 patient, 3%). The 
baseline diaphragm thickness at expiration was 1.4 (1.2–1.9) 
mm at the mechanical ventilation liberation. The fraction of 
inspired oxygen was 0.25 (0.25–0.30) before the liberation from 
HFNC. After HFNC liberation, 26 patients required 1–3 L / min 
of oxygen with a nasal cannula. The SpO2 did not change with 
and without HFNC (96% ± 2% vs. 96% ± 2%, p = 0.34).
Sixteen (40%) patients were classified as having normal di-
aphragm contraction, while 19 (48%) or 5 (13%) were classified 
as having decreased or paradoxical diaphragm contraction, 
respectively. The patients in these groups significantly differed 
in age and sex. In post hoc analysis, patients in the paradoxical 
diaphragm contraction group were younger than those in the 
normal or decreased diaphragm contraction groups (p = 0.02, 
p = 0.04, respectively). The remaining parameters did not differ 
significantly among the three groups.
In normal diaphragm contraction, thickening fraction in-
creased after HFNC liberation (27.0 ± 25.7 vs. 38.8 ± 34.5, 
p = 0.03 in HFNC vs. no HFNC ; Figure 2). Consequently, thick-
ening fraction did not change with or without HFNC in patients 
with decreased diaphragm contraction (8.9 ± 11.7 vs. 6.7 ± 5.2, 
p = 0.35). However, paradoxical contraction worsened after 
HFNC liberation (1.0 ± 10.2 vs. −10.3 ± 2.7, p = 0.04 in HFNC vs. 
no HFNC). Respiratory rate, excursion, contraction velocity, and 








(n = 16 ; 40%)
Decreased
(n = 19 ; 48%)
Paradoxical
(n = 5 ; 13%)
Age, years (mean [SD]) 69 ± 16 74 ± 9 70 ± 17 51 ± 20‡ 0.03
Sex (Male), n (%) 23 (58) 7 (44) 11 (58) 5 (100) 0.03
Body mass index, kg / m2 21.6 (20.0–24.1) 21.4 (18.9–23.4) 22.7 (20.5–24.8) 20.0 (18.8–21.0) 0.08
APACHE II 18 (12–26) 21 (15–28) 18 (12–22) 17 (12–32) 0.32
Post-operative admission, n (%) 18 (45) 7 (44) 10 (53) 1 (20) 0.40
Length of ICU stay, days 5 (4–9) 7 (5–9) 5 (3–7) 5 (2–10) 0.11
Duration of HFNC, days 2 (2–3) 2 (2–4) 2 (1–3) 2 (2–3) 0.85
The reason of HFNC use, n (%)
Post-extubation 29 (73) 13 (81) 13 (68) 3 (60)
Respiratory failure Type I 10 (25) 3 (19) 6 (32) 1 (20) 0.28
Respiratory failure Type II 1 (3) 0 (0) 0 (0) 1 (20)
Diaphragm thickness*, mm 1.4 (1.2–1.9) 1.6 (1.2–2.3) 1.3 (1.2–1.6) 1.4 (1.2–2.1) 0.57
SD = standard deviation, APACHE II = Acute Physiology and Chronic Health Evaluation II, ICU = intensive care unit, HFNC = high-
flow nasal cannula
*Diaphragm thickness was measured at expiration without high-flow nasal cannula.
†Normal, decreased, and paradoxical diaphragm contraction were defined as TF ≥  15%, TF 0%–15%, and < 0%, respectively.
Data were presented as median (interquartile range) unless otherwise indicated.
‡ Significant at p < 0.05 vs. normal and decreased diaphragm contraction by post hoc Steel–Dwass test.
Figure 2.　The change of diaphragm thickening fraction before and after HFNC liberation. A Normal diaphragm contraction ; thickening 
fraction, 27.0% ± 25.7% vs. 38.8% ± 34.5% with HFNC vs. without HFNC (p = 0.03). B Decreased diaphragm contraction ; thickening fraction, 
8.9% ± 11.7% vs. 6.7% ± 5.2% with HFNC vs. without HFNC (p = 0.35). C Paradoxical diaphragm contraction ; thickening fraction, 1.0% ± 10.2% 
vs. −10.3% ± 2.7% with HFNC vs. without HFNC (p = 0.04). Paired t-test was conducted for comparison using JMP 13.1.0 (SAS Institute, Cary, 
NC, USA). HFNC = high-flow nasal cannula.
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DISCUSSION
HFNC did not affect decreased diaphragm contraction in this 
study ; however, it attenuated paradoxical diaphragm contrac-
tion. The work of breathing was decreased by HFNC in patients 
without diaphragm dysfunction as reported (10, 11). The find-
ings of this study suggest that HFNC may have the potential role 
to manage patients with paradoxical diaphragm contraction.
Paradoxical diaphragm contraction was observed in 13% of 
the patients in this study. The prevalence of paradoxical dia-
phragm contraction has not been reported previously, and it 
may be more prevalent in the acute phase because we investi-
gated the prevalence in patients at the time of HFNC liberation. 
The mechanism of paradoxical diaphragm contraction is still 
unknown, and the differences in age and sex among patients 
require further investigation. Regarding diaphragm function, 
a previous study reported that the diaphragm acts as a brake 
during expiration to prevent lung collapse (12). HFNC main-
tains a positive end-expiratory pressure of 3 cmH2O at 30 L  / min 
(13), but the positive pressure is not provided after liberation 
from mechanical ventilation. This condition may cause paradox-
ical diaphragm contraction with thickening in the expiratory 
phase to prevent lung collapse. Although in previous studies 
paradoxical contractions were caused by spine position, phrenic 
nerve paralysis, and massive effusion (14-16), these conditions 
were excluded in the study setting. The paradoxical contraction 
was possibly caused by previous mechanical ventilation or some 
physiological conditions because this study included patients 
after extubation or with respiratory failure.
Contrary to thickening fraction, diaphragm excursion, veloci-
ty, and excursion–time index were not different with or without 
HFNC. Negative diaphragm excursion was not observed even in 
patients with paradoxical diaphragm contraction. The excursion 
is related to the inspired volume and cannot be used to assess di-
aphragm contraction (17-19). Therefore, these results mean that 
lung volume expanded even in paradoxical diaphragm function. 
Not only the diaphragm but also the intercostal muscles and 
other accessory respiratory muscles play an important role in 
expanding lung volume (20, 21). Thus, these respiratory muscles 
may have contributed to expanding lung volume. These results 
may have been also affected by intercostal muscles or accessory 
respiratory muscles although contraction velocity and excur-
sion–time index are used to estimate diaphragm work of breath-
ing (22, 23). Thus, these interactions of respiratory muscles may 
complicate the understanding of diaphragm excursion, velocity, 
and excursion–time index.
Decreased diaphragm contraction, defined as thickening frac-
tion < 15%, was observed in about half of the included patients. 
This frequent occurrence was because patients were included 
mostly after the use of mechanical ventilation. Indeed, the base-
line diaphragm thickness was 1.4 mm, which was lower than the 
average 2 mm in previous studies (24, 25). Although decreased 
diaphragm contraction was commonly observed in this study, 
HFNC did not affect the diaphragm contraction in patients with 
decreased diaphragm contraction. Noninvasive positive pres-
sure ventilation also might be insufficient for these respiratory 
supports because Marchioni et al. reported that decreased thick-
ening fraction < 20% indicated noninvasive ventilation failure in 
patients with acute exacerbations of chronic obstructive pulmo-
nary disease (26). On the other hand, HFNC decreased the work 
of breathing in patients with normal diaphragm contraction 
defined as ≥ 15%. This result is consistent with that of a previous 
study (18). Therefore, the measurements of diaphragm function 
in this study are reliable.
This study has several limitations. First, no patients re-
quired HFNC after HFNC liberation although HFNC posi-
tively contributed to paradoxical diaphragm contraction. This 
is probably because patients whose HFNC was weaned to 30 
L  /  min for patients’ safety were included. Therefore, this study 
is a preliminary study suggesting the possible role of HFNC on 
paradoxical diaphragm contraction. HFNC may be crucial for 
patients with prominent paradoxical diaphragm contraction in 
the acute phase. Second, in this study, the observation was con-
ducted at the time of HFNC liberation. It is desirable to observe 
diaphragm function at the start of HFNC, but it is unethical if 
treatment is delayed due to the observational study. Therefore, 
as a first preliminary study, the change of diaphragm function 
was observed at HFNC liberation. Third, this study was based 
on a small sample size, particularly in patients with paradoxical 
diaphragm contraction. Thus, further studies are required to 
confirm these results in a large population.
Table 2.　Outcomes with and without high flow nasal cannula
Variables HFNC No HFNC p value
Normal diaphragm contraction
Respiratory rate, breaths / min 22 ± 5 21 ± 4 0.25
Excursion, cm 1.7 ± 0.5 1.6 ± 0.6 0.68
Contraction velocity, cm / sec 2.0 ± 0.7 1.8 ± 0.6 0.38
Excursion-time index, cm-sec 1.5 ± 0.5 1.5 ± 0.8 0.82
Decreased diaphragm contraction
Respiratory rate, breaths / min 22 ± 5 22 ± 5 0.69
Excursion, cm 1.2 ± 0.7 1.3 ± 0.9 0.33
Contraction velocity, cm / sec 1.5 ± 0.9 1.7 ± 1.2 0.53
Excursion-time index, cm-sec 1.0 ± 0.7 1.7 ± 1.2 0.23
Paradoxical diaphragm contraction
Respiratory rate, breaths / min 18 ± 3 16 ± 3 0.19
Excursion, cm 0.9 ± 0.5 1.1 ± 0.6 0.62
Contraction velocity, cm / sec 0.9 ± 0.5 1.2 ± 0.6 0.53
Excursion-time index, cm-sec 0.9 ± 0.6 1.1 ± 0.8 0.71
HFNC = high-flow nasal cannula
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CONCLUSION
In patients without diaphragm dysfunction, work of breathing 
decreased with HFNC but did not decrease in patients with 
decreased diaphragm contraction. However, paradoxical dia-
phragm contraction was decreased with HFNC. 
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